Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $400.5700 (1.61%) ($395.0100 - $405.7500) on Tue. Oct. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.65% (three month average) | RSI | 59 | Latest Price | $400.5700(1.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -0.825% in a week (0% probabilities). VXX(-12%) UUP(-11%) TLT(-7%) VIXM(-4%) IFRA(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.825% (StdDev 1.65%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $399.27(0.33%) | 10 Day Moving Average | $394.13(1.63%) | 20 Day Moving Average | $394.03(1.66%) | To recent high | -1.9% | To recent low | 14.1% | Market Cap | $42.472b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |